Tevogen Clears Both Nasdaq Continued-Listing Compliance Matters

Tevogen said it regained compliance with Nasdaq’s $50 million minimum market value of listed securities requirement for continued listing on the Nasdaq Global Market. The company said it received written confirmation from Nasdaq on September 29.

The notice resolved one of two previously disclosed compliance matters. On September 9, Nasdaq had confirmed that Tevogen met the minimum market value requirement for publicly held shares.

Tevogen said both requirements are now satisfied and the related Nasdaq compliance matters are closed. The company’s announcement cited Nasdaq Listing Rule 5450(B)(2)(A) for the listed-securities requirement and Rules 5450(B)(2)(C) and 5450(B)(3)(C) for the publicly held shares requirement.